A leading researcher issues a call for pills that deliver a full course of treatment in one swallow.
Peter Thiel was the first large investor in Facebook. Now he’s turning his investing skills to biotechnology.
Scientists are developing ways to edit the DNA of tomorrow’s children. Should they stop before it’s too late?
A startup called Thync will sell electrodes that you put on your head to improve your mood. The results may vary to a surprising degree.
Scientific advances and new business models are spurring investor confidence in biomedical-related ventures.
Stem-cell advocates pin their hopes on a method of treating diabetes.
A global network of millions of genomes could be medicine’s next great advance.
Availability: 1-2 years
A new method for growing human brain cells could unlock the mysteries of dementia, mental illness, and other neurological disorders.
Fast DNA-sequencing machines are leading to simple blood tests for cancer.
A phone attachment using cheap disposable cartridges rapidly tests for HIV and syphilis in a Rwandan trial.